MBTPS1 and colonic neoplasm: Findings from these studies indicate that S1P/SphK2 may play a protective role against cytotoxic effects of ATRA in colon cancer cells and encourage further studies into targeting this signaling axis to improve therapeutic efficacy of retinoids in colon cancer treatment.